abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

26 Apr 2007

Author:
AIDS Healthcare Foundation

AIDS Healthcare Foundation Says CalPERS to Question Abbott on Thailand Drug Blacklist [USA]

…AIDS Healthcare Foundation (AHF)…will host a press conference…regarding Abbott's volatile global drug pricing and policies for its AIDS drugs, and the company's recent actions against…Thailand… Last week, officials from [AHF] testified…about Abbott's drug pricing policies in Thailand before the Investment Committee of the California Public Employees Retirement System (CalPERS), which holds nearly $318 million in Abbott stock...In response, officials indicated that CalPERS would send a letter to Miles D. White, Abbott's Chief Executive Officer and Chairman of the Board concerning Abbott's recent actions and its AIDS drug pricing and policies in Thailand… [also refers to GlaxoSmithKline]